Brisbane startup says it can make mRNA vaccines for Australia
Date Posted – 17 March 2021 By Emma Koehn Sydney Morning Herald A Brisbane startup says it can make the active ingredients for the new generation of mRNA vaccines in Australia, but more government funding and training support are…
Dr Keith McLean and Theodora Elia-Adams Join BioMelbourne Network Board
12 November 2020 BioMelbourne Network is pleased to announce the appointment of Theodora Elia-Adams and Dr Keith McLean to the BioMelbourne Network Board. Keith McLean was elected as a Board Director at the 2020 Annual General Meeting on…
R&D Tax Incentive – Federal Budget (October 2021)
8 October 2020 As provided to BioMelbourne Network Members in Insider, 8 October 2020. The following is a summary of the R&D Tax Incentive. Overall the news is good with the Federal Government enhancing some aspects of the…
Updates: Senate Hearing for R&D Tax Incentive Bill (July – September 2020)
3 September 2020 A report was released today from the Senate Select Committee on Financial Technology and Regulatory Technology, chaired by Senator Andrew Bragg. This Committee was reviewing tax, regulation, capital and funding, skills and talent, and culture,…
Appointment of Jeff Malone as BioMelbourne Network Chief Executive Officer
Announcement Date: 17 June 2020 The Board of Directors of BioMelbourne Network is delighted to announce the appointment of Jeff Malone as Chief Executive Officer, effective 13th July 2020. Jeff holds a Bachelor of Electrical Engineering from…
Awards Highlight Women Leading Health and Innovation in Victoria
10 June 2020 Three extraordinary women were recognised today for their significant and inspirational leadership across Victoria’s health sector. Today’s BioMelbourne Network Women in Leadership Awards ceremony celebrated the three exceptional leaders, who were selected for their valuable…
Joint industry statement: Industry unites in call to back our biotechs to keep jobs during COVID-19
11 May 2020 Despite this being the life sciences industry’s ‘finest hour’ as it pivots to fast track COVID-19 vaccines, treatment and diagnostics and digital health solutions, the sector’s pre-revenues companies are calling for support to keep their…
“The world is different now” – a follow up from our virtual COVID-19 BioBreakfast
14 April 2020 On Thursday 19 March, BioMelbourne Network held a virtual BioBreakfast to discuss “how to make a vaccine and why is Victoria so important?”. Our keynote speaker, Dr Rob Grenfell, Director of CSIRO’s Health Biosecurity Business…
Skills Australia – Essential industry survey: biopharmaceutical and medical technology manufacturing industry (lodged by Tijan Ventures & BioMelbourne Network)
Posted to web – 31 March 2020 Lodged by Tijan Ventures & BioMelbourne Network 27 March 2020 Julie Stratford Industry Engagement Manager Skills Impact By Email Dear Julie, Essential industry survey: biopharmaceutical and medical technology manufacturing industry The…
“2020 is a different year”: A report from our virtual COVID-19 Vaccine BioBreakfast with Dr Rob Grenfell
24 March 2020 In just a few short months, COVID-19 has completely changed the world. From the initial novel Coronavirus outbreak in Wuhan to Europe becoming the new epicentre of infection, the world is at the mercy of…
BioMelbourne Network’s response to COVID-19 – Message from the Chair
17 March 2020 As a sector, we are experiencing unprecedented disruption as a result of the fast moving and evolving COVID-19 situation. In line with our commitment to providing a safe environment for members, staff and the broader…
Collaborate to Innovate – Key Themes from the 8th Annual Devices + Diagnostics Lab
12 March 2020 On Thursday 5th March 2020 BioMelbourne Network held their 8th Annual Devices + Diagnostics Lab, addressing the theme of Manufacturing, Markets and Minefields in the medical technology sector. Over 160 industry professionals spent the day…
